Target intelligence / Profile preview

Plasmodium falciparum hemozoin formation process

Molecular classification
Metabolic pathway, Biocrystallization process
01

Overview

The Plasmodium falciparum hemozoin formation process is a critical detoxification pathway utilized by the malaria parasite during its intraerythrocytic life cycle stage (Sullivan, 2002). As the parasite consumes host hemoglobin to obtain essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes (Coronado et al., 2014). To mitigate this toxicity, the parasite converts free heme into hemozoin, an insoluble and chemically inert crystalline polymer often referred to as malaria pigment. This biocrystallization occurs within the parasite acidic digestive vacuole and is essential for its survival. Many classic antimalarial drugs, particularly the quinoline class, exert their therapeutic effect by binding to heme or the growing crystal surface, thereby inhibiting hemozoin formation (Hempelmann, 2007). The resulting accumulation of toxic heme leads to the rapid death of the parasite, making this process one of the most successful and historically significant targets in antimalarial chemotherapy.

Other names
Heme detoxification pathwayHemozoin biocrystallizationMalaria pigment formationHeme polymerization process
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) within the parasite digestive vacuole (Egan, 2008; Hempelmann, 2007).

03

Biological functions

Heme detoxificationHemoglobin catabolismIron homeostasisParasite survival within host erythrocytes
04

Disease associations

Malaria
05

Safety considerations

Drug resistance mediated by mutations in PfCRT and PfMDR1 transportersCardiotoxicity (QT interval prolongation) associated with certain quinolinesNeuropsychiatric side effects (e.g., with mefloquine)Retinopathy (associated with long-term chloroquine use)
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin (malaria pigment)Plasmodium falciparum histidine-rich protein 2 (PfHRP2)Plasmodium falciparum histidine-rich protein 3 (PfHRP3)

Beyond the preview

Go deeper on Plasmodium falciparum hemozoin formation process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum hemozoin formation process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call